🇺🇸 FDA
Patent

US 8828399

Cytomegalovirus surface protein complex for use in vaccines and as a drug target

granted A61KA61K2039/505A61K39/12

Quick answer

US patent 8828399 (Cytomegalovirus surface protein complex for use in vaccines and as a drug target) held by THE TRUSTEES OF PRINCETON UNIVERSITY expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE TRUSTEES OF PRINCETON UNIVERSITY
Grant date
Tue Sep 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61K, A61K2039/505, A61K39/12, A61K39/245, A61P